Russell Investments Group
LUCD icon

Russell Investments Group’s Lucid Diagnostics LUCD Stock Holding History

Russell Investments Group’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Buy
1,583,608
+1,573,481
+15,537% +$2M ﹤0.01% 1925
2025
Q4 		$11K Buy
10,127
+2,200
+28% +$2.46K ﹤0.01% 3774
2025
Q3 		$8.01K Buy
+7,927
New +$8.66K ﹤0.01% 3828

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return

Russell Investments Group's LUCD Position: Q1 2026 in Review

Russell Investments Group increased its Lucid Diagnostics (LUCD) stake by 15,537% in Q1 2026, buying an estimated $2M and bringing the position to 1,583,608 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1925.

Russell Investments Group first reported a position in LUCD in Q3 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Russell Investments Group held 1,583,608 shares of Lucid Diagnostics worth $1.82M as of Q1 2026.
  • Russell Investments Group bought 1,573,481 Lucid Diagnostics shares in Q1 2026, an estimated $2M.
  • Lucid Diagnostics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #1925 holding.
  • Russell Investments Group first reported a position in Lucid Diagnostics in Q3 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.